These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 17380946)

  • 41. Biosafety considerations in laboratory design.
    Mortland KK; Mortland DB
    Clin Leadersh Manag Rev; 2003; 17(3):175-7. PubMed ID: 12813961
    [No Abstract]   [Full Text] [Related]  

  • 42. Infection control and the pregnant health care worker.
    Valenti WM
    Nurs Clin North Am; 1993 Sep; 28(3):673-86. PubMed ID: 8367332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biosafety concerns for shared flow cytometry core facilities.
    Schmid I; Merlin S; Perfetto SP
    Cytometry A; 2003 Dec; 56(2):113-9. PubMed ID: 14608639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventing TB transmission in the microbiology lab.
    Healthc Hazard Mater Manage; 1993 Sep; 6(12):8-9. PubMed ID: 10129492
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemical hazards in health care: high hazard, high risk, but low protection.
    McDiarmid MA
    Ann N Y Acad Sci; 2006 Sep; 1076():601-6. PubMed ID: 17119236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biological risk: applied procedure for risk assessment and planning of preventive and protective interventions].
    Benvenuti F; Lombardi R; Pastoni F
    Ann Ig; 2000; 12(4 Suppl 2):329-60. PubMed ID: 11100577
    [No Abstract]   [Full Text] [Related]  

  • 47. Protecting researchers from instrument biohazards.
    Hambleton P; Dedonato G
    Biotechniques; 1992 Sep; 13(3):450-3. PubMed ID: 1389178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biosafety of personnel of microbiological laboratories in the context of the Federal Law of the Russian Federation № 492-FZ of December 30, 2020 «On the biological safety of the Russian Federation».
    Matosova EV; Andryukov BG; Bynina MP; Drobot EI; Lyapun IN
    Klin Lab Diagn; 2022 Jul; 67(7):414-422. PubMed ID: 35924772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.
    Wurtz N; Papa A; Hukic M; Di Caro A; Leparc-Goffart I; Leroy E; Landini MP; Sekeyova Z; Dumler JS; Bădescu D; Busquets N; Calistri A; Parolin C; Palù G; Christova I; Maurin M; La Scola B; Raoult D
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1247-58. PubMed ID: 27234593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):401-4. PubMed ID: 18418346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prioritizing future resources for epidemiologic research on old and newly emerging occupational hazards.
    Checkoway H
    Med Lav; 2006; 97(2):175-81. PubMed ID: 17017344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious waste management and laboratory design criteria.
    Zaki AN; Campbell JR
    Am Ind Hyg Assoc J; 1997 Nov; 58(11):800-8. PubMed ID: 9373926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Semi-permanent make up and tattooing equipment: safety and health issues].
    Mansi A; Vonesch N; Tini MN; Di Mambro A; Cianotti R; Palmi S; Spagnoli G
    Ig Sanita Pubbl; 2004; 60(6):437-57. PubMed ID: 17206233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining and managing biohazardous waste in U.S. research-oriented universities: a survey of environmental health and safety professionals.
    Mecklem RL; Neumann CM
    J Environ Health; 2003; 66(1):17-22. PubMed ID: 12879576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Animal exposure surveillance: a model program.
    Lang YC
    AAOHN J; 2005 Sep; 53(9):407-12; quiz 414-5. PubMed ID: 16193913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melioidosis and safety in the clinical laboratory.
    Ashdown LR
    J Hosp Infect; 1992 Aug; 21(4):301-6. PubMed ID: 1355785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health, safety and environmental protection in a biological research laboratory.
    Peichl P
    Int Arch Occup Environ Health; 2000 Jun; 73 Suppl():S8-13. PubMed ID: 10968553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survey of Suspected Laboratory-Acquired Infections and Biosafety Practices in Research, Clinical, and Veterinary Laboratories in Karachi, Pakistan.
    Qasmi SA; Khan BA
    Health Secur; 2019; 17(5):372-383. PubMed ID: 31593511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.